Alzheimer’s disease
- Leqembi is the brand name of an active substance called lecanemab
- The EMA “concluded that the benefits of this medicine outweighed the risks”
© 2025 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.










